Project Grant HT9425261E248
Award Date 7/1/26
Completion Date 6/30/30
Dollars Obligated $4.2M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Buffalo, NY 14203, USA
Similar Awards
- Federal Project Grant Award Summary Health Research, Inc. (Roswell Park Division) received a $1.15M project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025, through June 30, 2029. The award supports research focused on leveraging infiltrating myeloid cells to improve therapeutic response to bispecific T cell-engaging (BiTE) secreting T cells in ovarian cancer treatment. This research initiative represents...
- Federal Project Grant Award Summary Health Research, Inc. (operating as Health Research At Roswell Park) received a $929,806 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2025, through June 30, 2029. The award supports research investigating the therapeutic application of infiltrating myeloid cells to enhance the efficacy of bite-secreting T cells in ovarian cancer treatment. This four-year...
- Federal Grant Award Summary Health Research, Inc., operating as Health Research At Roswell Park in Buffalo, New York, received a $173,500 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2025, through July 31, 2027. The award supports research focused on improving chemotherapy efficacy for small cell carcinomas of the bladder, a rare cancer type with significant clinical relevance to military...
- Federal Grant Award Summary Health Research, Inc. (Roswell Park Division) received a $958,389 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period June 1, 2026 through May 31, 2030. The award supports biomedical research initiatives conducted in Buffalo, New York, aligned with the DHA's mission to advance healthcare solutions for military service members and the American public. While the specific research...
- Federal Project Grant Award Summary Health Research, Inc.'s Roswell Park Division received a $2.39M project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective June 1, 2026 through May 31, 2030. The award supports research investigating stress, lifestyle, and immune pathways in aggressive breast cancer through an epitranscriptomic study approach. This research initiative aligns with the DHA's strategic focus on advancing...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded Beckman Research Institute of the City of Hope a $1.1M project grant effective June 1, 2026 through May 31, 2029 under the Military Medical Research and Development program (CFDA 12.420) to develop LRRC15-targeted Chimeric Antigen Receptor (CAR) T cell therapy for osteosarcoma treatment. This research initiative represents the DHA's investment in innovative cancer immunotherapy solutions with potential military and...
- Health Research, Inc. Inc Roswell Park Division Health Research Division (the Division) was awarded a $693,987 project grant from the Defense Health Agency through the Military Medical Research and Development program (CFDA 12.420). The grant will fund cancer immunotherapy research from June 1, 2023 through May 31, 2026. Specifically, the Division will investigate strategies to counter solid tumor antigen immune escape using CAR T cell therapies. As a past recipient of Defense Health Agency...
- Federal Grant Award Summary Health Research, Inc. (operating as Health Research at Roswell Park) received a $173,500 Project Grant awarded August 7, 2025, by the National Cancer Institute under the Cancer Treatment Research program (CFDA 93.395) to conduct a correlative clinical study investigating the effects of CXCR1/2 inhibition on the immune microenvironment of multiple myeloma patients. The research leverages preliminary findings demonstrating significant accumulation of CXCR2-positive...
- The U.S. Department of Defense's Defense Health Agency awarded Health Research, Inc. a $1,545,300 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "TARGETING MYCAF-DRIVEN CASTRATION-RESISTANT PROSTATE TUMOR GROWTH." The award, which has a performance period of May 1, 2024 to April 30, 2027, will enable Health Research, Inc.'s Roswell Park Division to perform biomedical research and provide scientific services to advance...
- This Project Grant award of $695,386.00 from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) supports research conducted by Health Research, Inc. (Roswell Park Division) to investigate translation dysregulation in metastatic breast cancer. The project aims to evaluate the implications of this phenomenon for disease outcomes and immunotherapy responses. The award period runs from March 1, 2024 to February 28, 2027. As a prime grantee,...